Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis